MOLECULIN BIOTECH INC (MBRX:NASDAQ)

$1.36 -0.83 (-37.8995%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 57

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed MOLECULIN BIOTECH INC (MBRX:NASDAQ) News Sources

Moleculin Announces Imminent MIRACLE Trial Unblinding as Blinded Data Continue to Significantly Outperform Historical Benchmarks

13-05-2026

yahoo.com

Nano-Cap Moleculin Biotech Approaches Key Leukemia Trial Data Unblinding

13-05-2026

yahoo.com

Moleculin Reports First Quarter 2026 Financial Results and Provides Clinical Update on Pivotal MIRACLE Trial

15-05-2026

yahoo.com

Moleculin Highlights Abstract Accepted for Poster Presentation at the 2026 ASCO Annual Meeting Highlighting Cardiac Safety Data for Annamycin

21-05-2026

yahoo.com

Moleculin Presents ASCO 2026 Data Demonstrating No Detectable Cardiotoxicity with Annamycin Despite Exposure Levels Far Exceeding Conventional Anthracycline Limits

29-05-2026

yahoo.com

Moleculin CEO, Walter Klemp, Highlights 45 Subject Enrollment Milestone in Recent Virtual Investor “What This Means” Segment

04-06-2026

yahoo.com

Independent Market Research Finds Strong Physician Intent to Prescribe Moleculin's Annamycin in Relapsed/Refractory AML

05-06-2026

yahoo.com

Moleculin Reports Positive Phase 2/3 MIRACLE Interim Results, With Annamycin Complete Remission Rates 3-fold Greater than Control

30-06-2026

yahoo.com

MBRX Stock Drops 25% As Moleculin Biotech's Interim Cancer Trial Data Falls Short Of Significance

30-06-2026

stocktwits.com

Moleculin CEO, Walter Klemp, Highlights Positive Preliminary MIRACLE Trial Results in Virtual Investor "What This Means" Segment

06-07-2026

yahoo.com

MOLECULIN BIOTECH INC (MBRX:NASDAQ) Sentiment Trend

0 25 50 75 100 49 85 65 79 79 69 49 11 2 78 13-05-2026 15-05-2026 21-05-2026 29-05-2026 04-06-2026 05-06-2026 30-06-2026 06-07-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

MOLECULIN BIOTECH INC (MBRX:NASDAQ) FAQs

toggle

What is the current price of MOLECULIN BIOTECH INC (MBRX:NASDAQ)?

The current price of MOLECULIN BIOTECH INC (MBRX:NASDAQ) is $1.36.


toggle

MOLECULIN BIOTECH INC (MBRX:NASDAQ) absolute price change since previous trading day?

The absolute price change of MOLECULIN BIOTECH INC (MBRX:NASDAQ) since the previous trading day is $-0.83.


toggle

MOLECULIN BIOTECH INC (MBRX:NASDAQ) percentage price change since previous trading day?

The percentage price change of MOLECULIN BIOTECH INC (MBRX:NASDAQ) since the previous trading day is -37.8995%.


toggle

What is the most recent average sentiment score for MOLECULIN BIOTECH INC (MBRX:NASDAQ)?

The most recent average sentiment score for MOLECULIN BIOTECH INC (MBRX:NASDAQ) is 57 out of 100.


toggle

What is the most recent average sentiment for MOLECULIN BIOTECH INC (MBRX:NASDAQ)?

The most recent sentiment for MOLECULIN BIOTECH INC (MBRX:NASDAQ) is .


SEC-8K** Filing Available For MOLECULIN BIOTECH INC (MBRX:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.